Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil Concentration for LMA Removal
NCT01931683Phase 4Completed
- Sponsor
- Ajou University School of Medicine
- Start
- Oct 2013
- Primary completion
- Feb 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of remifentanil, sponsored by Ajou University School of Medicine. Primary endpoint: Smooth removal of LMA. Started Oct 2013; status: completed.
02
Drugs
remifentanil
Beyond the preview
Go deeper on NCT01931683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01931683.